Media
Megna Health Receives Point of Care With Fingerstick, Emergency Use Authorization from the FDA for its Rapid COVID-19 IgM/IgG Combo Antibody Test
EXTON, PA. (PRWEB) APRIL 23, 2021 Megna Health announced today that its Rapid COVID-19 IgM/IgG Test, previously authorized for use under the U.S. Food and Drug Administration (FDA) Emergency Use Authorization, is now available for Point of Care Settings. The test Read more…